Condition: Sepsis-related Myocarditis · Sponsor: Jimma University
This prospective cohort study aims to investigate the cardiac manifestations of sepsis and their influence on disease outcomes among adult patients at Jimma University Medical Center, Ethiopia, from May 2025 to May 2026. The research will include adults aged 18 and older with sepsis, categorizing them based on the presence or absence of cardiac involvement, which will be assessed through clinical symptoms, biomarkers, ECG, and echocardiographic findings. The study will evaluate the persistence of cardiac abnormalities, functional capacity, and survival over one year, utilizing structured data collection and advanced statistical methods, including survival analysis and regression techniques, to identify predictors of adverse outcomes.
This description comes directly from the study's public registry record.
Kedir Negesso Tukeni, MD, Internist, Cardiologist · 0913521475 · Kedir.negesso@ju.edu.et
Kidus Tesfaye Bezabih, MD, Internist · 0920197780 · kdstesfaye@gmail.com
Always discuss trial participation with your own doctor first.
| Jimma University Hospital | Jimma, Oromiya, Ethiopia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07079605